Company / Profit Margin
ORAMED PHARMACEUTICALS INC. Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-953.0%
FY2025
5-year range
-1352.6% / 379.7%
FY2021-FY2025
Trend
-351.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin changed -351% YoY in FY2025, a notable deviation from the 9-year average annual change of -43%.
Based on SEC 10-K filings.
-953.0% in FY2025 with a 5-year CAGR of -421.9%.
Improved from -1352.6% to -953.0% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -102.5pp
- 5-Year Change
- -421.9pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin decreased 351.0% year-over-year.
- Peak profit margin was recorded in FY2024.
- Lowest profit margin in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -953.0% | -351.0% |
| FY2024 | 379.7% | +128.1% |
| FY2023 | -1352.6% | -59.0% |
| FY2022 | -850.5% | -100.2% |
| FY2021 | -424.8% | +20.0% |
| FY2020 | -531.1% | -24.5% |
| FY2019 | -426.7% | +75.1% |
| FY2018 | -1710.5% | -51.6% |
| FY2017 | -1128.2% | -27.0% |
| FY2016 | -888.6% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026